Trexquant Investment LP Biote Corp. Transaction History

Trexquant Investment LP

$6.33 Billion
Q2 2024

A detailed history of Trexquant Investment LP transactions in Biote Corp. stock. As of the latest transaction made, Trexquant Investment LP holds 46,307 shares of BTMD stock, worth $241,259. This represents 0.01% of its overall portfolio holdings.

Number of Shares

46,307

Holding current value

$241,259

% of portfolio

0.01%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 13, 2024	BUY	$5.44 - $7.47 $251,910 - $345,913	46,307 New	46,307 $345,000
Q3 2023 Nov 13, 2023	BUY	$4.73 - $7.83 $91,478 - $151,432	19,340 New	19,340 $99,000

Others Institutions Holding BTMD

# of Institutions

Shares Held

15.9M

Call Options Held

Put Options Held

325 Capital LLC New York, NY

3.77M
Shares

$19.6 Million
12.3% of portfolio
Bandera Partners LLC New York, NY

2.44M
Shares

$12.7 Million
6.61% of portfolio
Black Rock Inc. New York, NY

1.61M
Shares

$8.36 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.38M
Shares

$7.19 Million
0.0% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

1.29M
Shares

$6.69 Million
0.05% of portfolio

View Full List

About biote Corp.

Ticker BTMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 7,574,270
Market Cap $39.5M
Description
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...

More about BTMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account